Conshohocken-based AmerisourceBergen Establishes a $150M fund to partner with emerging health companies looking to transform health care, writes John George for the Philadelphia Business Journal.

The new fund, called AB Health Ventures, will invest in partnerships with companies that have a healthcare focus on people and animals. The new fund will operate as a “wholly-owned subsidiary of AmerisourceBergen listed as NYSE: ABC.

To help manage the fund, ASB has Touchdown Ventures, a firm specializing in corporate venture capital in Haddonfield, New Jersey.

“Over the years, we have made thoughtful and strategic investments to advance the development and delivery of health care, enable access and create even stronger stability across the supply chain,” said Steve Collis, chairman and CEO of the Conshohocken-based wholesale pharmaceutical distribution and services company.

The idea is that the fund will focus on investments in companies and entrepreneurs around the world who are pursuing bold ideas in pharmacy and distribution, practicing solutions for health care providers, and animal health.

“The creation of AB Health Ventures will build on our track record of success as we identify meaningful partnerships that will bring emerging health care solutions to market, and create healthier futures for all,” explained Collis.

To read more about the new AmerisourceBergen $150M venture fund, AB Health Ventures, for emergent health care companies, check out the Philadelphia Business Journal.